Cost-utility analysis of timolol versus latanoprost versus travoprost in the treatment of glaucoma and ocular hypertension

被引：0
|
作者：
Lilliu, H
Le Pen, C
Berdeaux, G
机构：
[1] Alcon Labs Inc, Rueil Malmaison, France
[2] Clp Sante, Paris, France
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61457-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：552 / 553
页数：2
相关论文
共 50 条
  • [1] Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension
    Pfeiffer, Norbert
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (07) : 1065 - 1071
  • [2] Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension
    Norbert Pfeiffer
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 1065 - 1071
  • [3] Cost Effectiveness of Travoprost versus a Fixed Combination of Latanoprost/Timolol in Patients with Ocular Hypertension or Glaucoma Analysis Based on the UK General Practitioner Research Database
    De Natale, Renato
    Lafuma, Antoine
    Berdeaux, Gilles
    CLINICAL DRUG INVESTIGATION, 2009, 29 (02) : 111 - 120
  • [4] Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis
    Takeuchi, Masaru
    Kanda, Takayuki
    Taguchi, Manzo
    Shibata, Masaki
    Mine, Izumi
    Sakurai, Yutaka
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (01) : 105 - 110
  • [5] Cost-Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany
    Lazzaro, Carlo
    van Steen, Cecile
    Billeit, Stephan
    Frauenknecht, Heinrich
    Kallen, Christopher
    Pfennigsdorf, Stefan
    Thelen, Ulrich
    Angelillo, Luigi
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 323 - 337
  • [6] Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in France
    Lazzaro, Carlo
    van Steen, Cecile
    Aptel, Florent
    Schweitzer, Cedric
    Angelillo, Luigi
    JOURNAL OF OPHTHALMOLOGY, 2022, 2022
  • [7] Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
    Netland, PA
    Landry, T
    Sullivan, EK
    Andrew, R
    Silver, L
    Weiner, A
    Mallick, S
    Dickerson, J
    Bergamini, MVW
    Robertson, SM
    Davis, AA
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (04) : 472 - 484
  • [8] Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension - Reply
    Netland, PA
    Landry, T
    Sullivan, EK
    Andrew, R
    Silver, L
    Weiner, A
    Mallick, S
    Dickerson, J
    Bergamini, MVW
    Robertson, SM
    Davis, AA
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (05) : 732 - 733
  • [9] Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France
    Payet, Stephanie
    Denis, Philippe
    Berdeaux, Gilles
    Launois, Robert
    CLINICAL DRUG INVESTIGATION, 2008, 28 (03) : 183 - 198
  • [10] Assessment of the Cost Effectiveness of Travoprost versus Latanoprost as Single Agents for Treatment of Glaucoma in France
    Stéphanie Payet
    Philippe Denis
    Gilles Berdeaux
    Robert Launois
    Clinical Drug Investigation, 2008, 28 : 183 - 198
12345